MUC16 and cancer: In the total OC patient cohort (OCTotal), none of the key clinical factors differed significantly between the OCwt and OCvar groups, including age, cancer stage, BRCA variant type (Supplementary Methods), preoperative CA125 concentration, or preoperative platelet concentration (Bonferroni corrected p-value > 0.05/7 = 0.0071).